| abstract |
The invention relates to compounds of formula (I) or their pharmaceutically acceptable salts, where A represents CR or N; B represents CR or N; D represents CR or N; where zero or one of A, B and D represents N; X is a bond or —NR—; L is a bond or —CH, and the remaining substituents are defined in the claims. These compounds are modulators of TNFα. Such compounds and pharmaceutical compositions containing them are useful in the treatment of inflammatory and autoimmune diseases associated with TNFα activity. |